Information on adjustable pressure Strata shunts used for treating hydrocephalus in children and adults
Information about The O-arm® multi-dimensional surgical imaging platform for use in spine, orthopaedic, and trauma-related surgeries.
Information on the NIM-Eclipse® intraoperative nerve monitoring system used to alert physicians during surgery of changes in nerve potentials – a possible indicator of nerve injury.
Information on the Midas Rex line of motors, attachments and tools for neurosurgery, spinal, orthopaedic and ENT surgical procedures.
Information on the Duet™ External Drainage and Monitoring System used for the management of short-term external cerebrospinal fluid drainage from either the ventricles of the brain or the sub-arachnoid lumbar space, and the TiMesh® system line of plates, screws and meshes for use in bony reconstructive cranial neurosurgical procedures.
Information about a series of minimally invasive spinal surgery advances developed by Medtronic Sofamor Danek, which define a new direction for spinal surgery by allowing surgeons to perform surgery through incisions less than an inch in length while leaving muscle virtually intact. Products under the MAST banner include the CD HORIZON® SEXTANT™ Spinal System for spinal fusion, METRx™ MicroDiscectomy System for herniated discs and CD HORIZON® ECLIPSE® Spinal System for scoliosis.
Information about the use of INFUSE® Bone Graft with the LT-CAGE® Lumbar Tapered Fusion Device to treat degenerative disc disease; it's estimated that, in 2002, more than 190,000 Americans will undergo lumbar spinal fusion surgeries to ease their debilitating back pain and get them back on their feet. INFUSE® Bone Graft contains recombinant human bone morphogenetic protein (rhBMP-2), the genetically engineered version of a naturally occurring protein that is capable of initiating bone growth, or bone regeneration, in specific, targeted areas in the spine. Using INFUSE® Bone Graft with the LT-CAGE® device in spine surgery reduces the pain and complications associated with treating degenerative disc disease by eliminating the second surgery required to harvest bone from a patient’s hip, as is done in traditional spinal fusion procedures.
Information about INFUSE® Bone Graft for use in the treatment of acute, open tibia fractures in adults.
Information about renal denervation, an investigational treatment for uncontrolled hypertension in the United States. Renal denervation is not approved by the U.S. Food and Drug Administration. Its use in the United States is limited by U.S. law to clinical studies approved by the FDA.
For more information, click here.
Information about Targeted Drug Delivery treatment options.
Information about Medtronic spinal cord stimulation and AdaptiveStim™ Technology.
Information about sacral neuromodulation, a proven treatment option for bladder control and bowel control.
Information about the Guardian™ Connect Continuous Glucose Monitoring (CGM) system, the first smart standalone CGM system to help people with diabetes using multiple daily injections (MDI) stay ahead of high and low glucose events.
Information about the MiniMed® 770G system which features smartphone connectivity and an expanded age indication down to the age of 2 years old.
Information about the MiniMed™ 780G system, a next generation closed loop insulin pump system for the treatment of type 1 diabetes.
Information about the MiniMed® 670G system, the world’s first hybrid closed loop system for individuals with type 1 diabetes.
Information about Medtronic insulin pump therapy, continuous glucose monitoring and therapy management software.
Information about the Melody® Transcatheter Pulmonary Valve, which offers a non-surgical valve replacement option for congenital heart disease patients. Melody is the first transcatheter heart valve to receive FDA approval and represents a significant development in the treatment of congenital heart disease.
To learn more, please visit Melody-TPV.com.
Information about heart valve disease and heart valve replacement.
Information about coronary artery disease (CAD) and its minimally invasive treatment with the Resolute Drug-Eluting Stent (DES) Platform.
Information about a new approach to traditional bypass surgery.
Sudden cardiac arrest (SCA) is a sudden, abrupt loss of heart function. Most SCA episodes are caused by the rapid and/or chaotic activity of the heart known as ventricular tachycardia (VT) or ventricular fibrillation (VF). These are abnormalities of the heart’s electrical conduction system. SCA claims the lives of nearly 1,000 Americans each day – many of these deaths are preventable.
Information about the Reveal LINQ II ICM designed to give physicians valuable insights that could help identify the cause of unexplained fainting.
Information about the Reveal LINQ II ICM – a miniaturized implantable cardiac monitor designed to help physicians quickly and accurately diagnose irregular heartbeats.
Information about devices implanted in the chest to treat hearts that tend to beat too slowly to support the needs of the human circulatory system.